Skip to main content

Advertisement

SpringerLink
Log in

Current status and developments in diagnosis and therapy of multiple myeloma

  • Meeting Report
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Conflict of interest statement

The manuscript was critically reviewed by Dr. Axel Glasmacher, medical director Celgene Germany.

Author information

Authors and Affiliations

  1. Department of Hematology and Oncology, University of Heidelberg, Im Neuenheimer Feld 410, Heidelberg, Germany

    Jens Hillengass, Kai Neben & Hartmut Goldschmidt

  2. National Center for Tumor Diseases, Heidelberg, Germany

    Hartmut Goldschmidt

Authors
  1. Jens Hillengass
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kai Neben
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hartmut Goldschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jens Hillengass.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hillengass, J., Neben, K. & Goldschmidt, H. Current status and developments in diagnosis and therapy of multiple myeloma. J Cancer Res Clin Oncol 136, 151–155 (2010). https://doi.org/10.1007/s00432-009-0676-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-009-0676-3

Keywords

Search

Navigation